On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq’s opening bell in New York, marking the company’s awaited initial public offering. Founded in 2008 by ...

Caris Life Sciences bumped up the pricing of its IPO to raise more than $494.1 million in its Nasdaq debut—well over the range it first proposed last week, in the vicinity of $400 million.

Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, raised $494 million in a US initial public offering that priced above the top of its ...

Caris Life Sciences Inc., a health care company that uses technology to help diagnose and treat cancer, raised $494 million in a U.S. initial public offering that priced above the top of its ...

Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the pricing of its initial public offering of ...

The IPO price was planned between the $19 and $20 range, up from the previous $16 and $18 planned price. The current pricing would value Caris Life Sciences at around $5.9 billion.

In addition, Caris has granted the underwriters a 30-day option to purchase up to an additional 3,529,411 shares of common stock at the initial public offering price, less underwriting discounts ...

See also: Benzinga IPO Calendar About Caris Life Sciences, Inc Caris Life Sciences, Inc is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer.

IRVING, Texas, June 17, 2025 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the ...

Today’s IPO for Caris Life Sciences (CAI) is indicated to open at $30 after pricing at $21. the company priced 23,529,412 shares in the IPO BofA Securities, J.P. Morgan and Goldman Sachs & Co ...

Caris Life Sciences (CAI) stock is expected to make its trading debut on Wednesday after the company priced its IPO at $21/share. Read more here.

Caris Life Sciences applies AI and machine learning to patient samples to detect cancer and as a companion diagnostic guiding the use of targeted cancer therapies. As a commercial-stage company ...